Security key
75382E109
RAPT Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RAPT)
CUSIP: 75382E109
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 131,135,934
- Total 13F value
- $159,984,594
- Share change
- +4,248,382
- Put/Call ratio
- 0.24%
- SEC-reported price per share
- $1.22
- Number of holders
- 89
- Value change
- +$4,424,695
- Number of buys
- 40
- Number of sells
- 40
- Shares outstanding
- 27,725,634
Holder snapshot
7 signals
Show 1 more signal
Security identity
1 source field
Report period
Q1 2025
Institutions
89
Top holders
10
RAPT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2025
Previous quarter: Q4 2024
RAPT Therapeutics, Inc. SEC filings
RAPT Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 75382E109
Recent filing periods:
Ownership snapshot
Top reported holders of RAPT - RAPT Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Medicxi IV LP
Disclosed value leader
Medicxi Ventures Manageme...
Comparable rows
15/15
Latest evidence
31 Mar 2025
13D/G
13F
3/4/5
Lead comparable stake: 17%
13D/G row: Medicxi IV LP
Showing 1-6 of 15 holder rows.
Quick read
Medicxi IV LP leads the comparable SEC ownership view at 17%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
Medicxi IV LP
17%
TCG Crossover GP II, LLC
10%
Redmile Group, LLC
9.9%
Deep Track Capital, LP
9.9%
Foresite Capital Fund VI LP
9.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Medicxi IV LP |
13D/G
Medicxi IV GP Limited
|
17%
|
$19,446,240
22,352,000 shares
|
$0 | 27 Dec 2024 |
| TCG Crossover GP II, LLC |
13D/G
|
10%
|
$11,478,006
13,193,110 shares
|
$0 | 27 Dec 2024 |
| Redmile Group, LLC |
13D/G
13F
Company
|
9.9%
|
$12,121,231
13,932,449 shares
|
$0 | 31 Dec 2024 |
| Deep Track Capital, LP |
13D/G
13F
Company
|
9.9%
|
$12,280,920
14,116,000 shares
|
$0 | 23 Dec 2024 |
| Foresite Capital Fund VI LP |
13D/G
Foresite Capital Fund VI, L.P.
|
9.3%
|
$10,875,000
12,500,000 shares
|
$0 | 23 Dec 2024 |
| VANGUARD GROUP INC |
13D/G
13F
The Vanguard Group · Company
|
6.3%
|
$7,202,554
8,278,798 shares
|
+$4,651,367 | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
89
Shares
131,135,934
Rows available
89
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
89
Q1 2025 holders
89
Holder diff
0
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend